Eloxx Pharmaceuticals, Inc. (ELOX) › Net IncomeEloxx Pharmaceuticals, Inc. (ELOX) — Net IncomeAnnual figures by fiscal year, from SEC filings.1999: -$1.17M2000: -$3.35M2001: -$2.03M2002: -$3.02M2003: -$2.78M2004: -$3.73M2005: -$2.98M2006: -$3.31M2007: -$3.25M2008: -$4.60M2009: -$5.73M2010: -$13.38M2011: -$7.27M2012: -$5.07M2013: -$6.12M2014: -$9.23M2015: -$6.41M2016: -$9.85M2017: -$21.21M2018: -$47.19M2019: -$50.87M2020: -$34.58M2021: -$66.73M2022: -$36.06M2023: -$17.05M2024: -$3.14M2025: -$6.00M-$6.00M1999Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$6.00M-90.7%2024-$3.14M+81.6%2023-$17.05M+52.7%2022-$36.06M+46.0%2021-$66.73M-93.0%2020-$34.58M+32.0%2019-$50.87M-7.8%2018-$47.19M-122.4%2017-$21.21M-115.4%2016-$9.85M-53.7%2015-$6.41M+30.6%2014-$9.23M-50.7%2013-$6.12M-20.9%2012-$5.07M+30.3%2011-$7.27M+45.7%2010-$13.38M-133.7%2009-$5.73M-24.5%2008-$4.60M-41.5%2007-$3.25M+1.9%2006-$3.31M-11.3%2005-$2.98M+20.1%2004-$3.73M-34.2%2003-$2.78M+8.1%2002-$3.02M-48.6%2001-$2.03M+39.2%2000-$3.35M-186.3%1999-$1.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share